Accelerated programmed cell death, or apoptosis, contributes to the CD
4(+) T-cell depletion characteristic of infection by human immunodefic
iency virus (HIV). It has therefore been proposed that limiting apopto
sis may represent a therapeutic modality for HIV infection. We found,
however, that T leukemia cells or peripheral blood mononuclear cells (
PBMCs) exposed to HIV-1 underwent enhanced viral replication in the pr
esence of the cell death inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp-fl
uoromethylketone (z-VAD-fmk). Furthermore, z-VAD-fmk, which targets th
e pro-apoptotic interleukin-1 beta-converting enzyme (ICE)-like protea
ses, stimulated endogenous virus production in activated PBMCs derived
from HIV-1-infected asymptomatic individuals. These findings suggest
that programmed cell death may serve as a beneficial host mechanism to
limit HIV spread and that strategies to inhibit it may have deleterio
us consequences for the infected host.